Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New ...

The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.

A new study reveals that scratching is not just an annoying reflex — it plays a dual role in immune activation and pathogen ...

Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.

In addition to medication, you can use topical treatments — in gel, patch or cream form, as a healing solution for cold sores ...

As everyone knows, scratching at chronically itchy skin only makes the problem worse. A new device is claimed to help stop ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

Apple cider vinegar is fermented juice made from apples. It may be useful in blood sugar management, weight loss, and ...

Swiss dermatology company Galderma has announced two European approvals for Nemluvio (nemolizumab) to treat both atopic ...